DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression

Following DNA damage caused by exogenous sources, such as ionizing radiation, the tumour suppressor p53 mediates cell cycle arrest via expression of the CDK inhibitor, p21. However, the role of p21 in maintaining genomic stability in the absence of exogenous DNA-damaging agents is unclear. Here, using live single-cell measurements of p21 protein in proliferating cultures, we show that naturally occurring DNA damage incurred over S-phase causes p53-dependent accumulation of p21 during mother G2- and daughter G1-phases. High p21 levels mediate G1 arrest via CDK inhibition, yet lower levels have no impact on G1 progression, and the ubiquitin ligases CRL4Cdt2 and SCFSkp2 couple to degrade p21 prior to the G1/S transition. Mathematical modelling reveals that a bistable switch, created by CRL4Cdt2, promotes irreversible S-phase entry by keeping p21 levels low, preventing premature S-phase exit upon DNA damage. Thus, we characterize how p21 regulates the proliferation-quiescence decision to maintain genomic stability.

[1]  Chris Bakal,et al.  Cell shape and the microenvironment regulate nuclear translocation of NF-κB in breast epithelial and tumor cells. , 2015, Molecular systems biology.

[2]  G. Lahav,et al.  Encoding and Decoding Cellular Information through Signaling Dynamics , 2013, Cell.

[3]  G. Lahav,et al.  Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit. , 2016, Cell reports.

[4]  Galit Lahav,et al.  Basal Dynamics of p53 Reveal Transcriptionally Attenuated Pulses in Cycling Cells , 2010, Cell.

[5]  D. Rousseau,et al.  Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway , 1999, Oncogene.

[6]  E. Kipreos,et al.  Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. , 2012, Trends in cell biology.

[7]  Bard Ermentrout,et al.  Simulating, analyzing, and animating dynamical systems - a guide to XPPAUT for researchers and students , 2002, Software, environments, tools.

[8]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[9]  Takeshi Norimatsu,et al.  Encoding and Decoding , 2016 .

[10]  Guo-Jun Zhang,et al.  Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex , 2004, Nature.

[11]  Robert F. Murphy,et al.  A neural network classifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells , 2001, Bioinform..

[12]  M. Debatisse,et al.  Stepwise Activation of the ATR Signaling Pathway upon Increasing Replication Stress Impacts Fragile Site Integrity , 2013, PLoS genetics.

[13]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[14]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[15]  S. Reed,et al.  Nuclear Accumulation of p21Cip1 at the Onset of Mitosis: a Role at the G2/M-Phase Transition , 1998, Molecular and Cellular Biology.

[16]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[17]  R. Abraham.  Cell cycle checkpoint signaling through the ATM and ATR kinases. , 2001, Genes & development.

[18]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[19]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[20]  Daniel Rueckert,et al.  2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI) , 2012, ISBI 2012.

[21]  Sabrina L. Spencer,et al.  The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit , 2013, Cell.

[22]  B. Neumann,et al.  53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress , 2011, Nature Cell Biology.

[23]  D. Coppola,et al.  Loss of the cell cycle inhibitors p21Cip1 and p27Kip1 enhances tumorigenesis in knockout mouse models , 2002, Oncogene.

[24]  Jan M Skotheim,et al.  Start and the restriction point. , 2013, Current opinion in cell biology.

[25]  Sabrina L. Spencer,et al.  Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states , 2014, Proceedings of the National Academy of Sciences.

[26]  Anindya Dutta,et al.  PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. , 2008, Genes & development.

[27]  I. Ial,et al.  Nature Communications , 2010, Nature Cell Biology.

[28]  Joakim Jalden,et al.  Global Linking of Cell Tracks Using the Viterbi Algorithm , 2015, IEEE Transactions on Medical Imaging.

[29]  S. Jackson,et al.  CRISPR-Cas9D10A nickase-based genotypic and phenotypic screening to enhance genome editing , 2016, Scientific Reports.

[30]  Yangyang Zhao,et al.  BioModels: ten-year anniversary , 2014, Nucleic Acids Res..

[31]  Yan Geng,et al.  Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells , 2009, Cell.

[32]  P. Jeggo,et al.  DNA repair, genome stability and cancer: a historical perspective , 2015, Nature Reviews Cancer.

[33]  S. Ferrari,et al.  Author contributions , 2021 .

[34]  S. Elledge,et al.  Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.

[35]  Youngjo Kim,et al.  The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. , 2008, Genes & development.

[36]  D. Rousseau,et al.  Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway , 1999, Oncogene.

[37]  S. Reed,et al.  Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E. , 1996, The EMBO journal.

[38]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[39]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[40]  B. Stillman,et al.  Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro , 1994, Nature.

[41]  Stephen J. Elledge,et al.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest , 1994, Cell.

[42]  Bernard Ducommun,et al.  p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells , 1998, Oncogene.

[43]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[44]  M. Pagano,et al.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. , 2004, Nature.

[45]  M. Pagano,et al.  Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer , 2008, Nature Reviews Cancer.

[46]  Jeremy E. Purvis,et al.  p53 Dynamics Control Cell Fate , 2012, Science.

[47]  Anindya Dutta,et al.  p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.

[48]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[49]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[50]  Nagiza F. Samatova,et al.  The sorting direct method for stochastic simulation of biochemical systems with varying reaction execution behavior , 2006, Comput. Biol. Chem..

[51]  G. Dotto,et al.  p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Gervais,et al.  Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Walter,et al.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. , 2011, Genes & development.

[54]  M. Serrano,et al.  Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. , 2001, Cancer research.

[55]  John J Tyson,et al.  Exploring the roles of noise in the eukaryotic cell cycle , 2009, Proceedings of the National Academy of Sciences.

[56]  V. Gottifredi,et al.  Cyclin Kinase-independent role of p21CDKN1A in the promotion of nascent DNA elongation in unstressed cells , 2016, eLife.

[57]  K. Cimprich,et al.  ATR: an essential regulator of genome integrity , 2008, Nature Reviews Molecular Cell Biology.

[58]  H. Nishitani,et al.  CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1Cdt2 Pathway during S Phase and after UV Irradiation* , 2008, Journal of Biological Chemistry.

[59]  R. Poon,et al.  On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells. , 2000, Biochemistry.

[60]  F. Rosselli,et al.  ERCC1 and MUS81–EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis , 2013, Nature Cell Biology.

[61]  Y. Liu,et al.  MUS81 promotes common fragile site expression , 2013, Nature Cell Biology.

[62]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[63]  Y. Shamoo,et al.  Structural and thermodynamic analysis of human PCNA with peptides derived from DNA polymerase-delta p66 subunit and flap endonuclease-1. , 2004, Structure.

[64]  Daniel T Gillespie,et al.  Stochastic simulation of chemical kinetics. , 2007, Annual review of physical chemistry.

[65]  C. Kemp,et al.  Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis , 1999, Oncogene.

[66]  W. V. van Cappellen,et al.  Nuclear Dynamics of PCNA in DNA Replication and Repair , 2005, Molecular and Cellular Biology.

[67]  Chris Bakal,et al.  Molecular Systems Biology Peer Review Process File Cell Shape and the Microenvironment Regulate Nuclear Translocation of Nf-κ B in Breast Epithelial and Tumor Cells Transaction Report , 2022 .

[68]  Chris Bakal,et al.  A Dynamical Framework for the All-or-None G1/S Transition , 2016, Cell systems.

[69]  F. E. Yoder,et al.  Chromosome fragile sites. , 1985, Cancer genetics and cytogenetics.

[70]  M. Pagano,et al.  Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase* , 2003, Journal of Biological Chemistry.

[71]  S. Bekker-Jensen,et al.  Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1 , 2005, The Journal of cell biology.

[72]  A. Zetterberg,et al.  Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[73]  A. Hindmarsh,et al.  CVODE, a stiff/nonstiff ODE solver in C , 1996 .

[74]  S. Jentsch,et al.  PCNA, the Maestro of the Replication Fork , 2007, Cell.

[75]  A. Tyner,et al.  Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon , 2004, Oncogene.

[76]  J. Diffley,et al.  Regulation of Early Events in Chromosome Replication , 2004, Current Biology.